CHO Pharma (ROCO:6586) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is CHO Pharma Days Payable?

CHO Pharma's average Accounts Payable for the six months ended in Jun. 2024 was NT$0.00 Mil. CHO Pharma's Cost of Goods Sold for the six months ended in Jun. 2024 was NT$0.53 Mil. Hence, CHO Pharma's Days Payable for the six months ended in Jun. 2024 was 0.00.

The historical rank and industry rank for CHO Pharma's Days Payable or its related term are showing as below:

ROCO:6586's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 127.14
* Ranked among companies with meaningful Days Payable only.

CHO Pharma's Days Payable stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

CHO Pharma Days Payable Historical Data

The historical data trend for CHO Pharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CHO Pharma Days Payable Chart

CHO Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

CHO Pharma Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CHO Pharma's Days Payable

For the Biotechnology subindustry, CHO Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CHO Pharma's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CHO Pharma's Days Payable distribution charts can be found below:

* The bar in red indicates where CHO Pharma's Days Payable falls into.

CHO Pharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

CHO Pharma's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

CHO Pharma's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0.534	*	365 / 2
=	0					/	0.534	*	365 / 2
=	0.00

CHO Pharma Days Payable Related Terms

Thank you for viewing the detailed overview of CHO Pharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

CHO Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CHO Pharma Inc (ROCO:6586) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, 18F, Building F, Nangang, Taipei, TWN, 11503

Website

http://www.chopharma.com

CHO Pharma Inc is a biopharmaceutical company mainly focused on the development and commercialization of innovative products based on the proprietary glycan engineering technologies. It offers antibodies, such as CHO-H01, CHO-H02, CHO-A04 for cancer; CHO-H03, an antibody for autoimmune disease; CHO-S05 dual-effect anti-flu drugs; and CHO-V06 glycan-based vaccines and drugs.

CHO Pharma Headlines

No Headlines